The impact of growth modulation of liver carcinogenesis
The impact of growth modulation of liver carcinogenesis
批准号:
7081233
负责人:
XIAO-MING YIN
金额:
$28.08万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2010-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hepatocellular carcinoma (HCC) is a frequent end-stage outcome of many chronic liver diseases, such as viral hepatitis and alcoholic liver disease, and of exposure to chemical carcinogens. The development of liver cancer is a slow process that involves multiple stages of initiation, promotion and progression, encompassing a long period. Molecular events controlling the process have not been fully elucidated, particularly at the early stage of tumor initiation. In a chemical hepatocarcinogenic model employing the classical carcinogen, diethylnitrosamine, we found that deletion of Bid, a pro-death Bcl-2 family protein, paradoxically suppressed the carcinogenesis starting at the early stage of microfoci development, when the capability of hepatocyte proliferation is critically involved. This early effect had a significant impact on overall tumor development examined 8-12 months after diethylnitrosamine administration. Further studies revealed a novel function of Bid in promotion of cell cycle entry and in regulation of intracellular calcium homeostasis. We hypothesize that Bid facilitates the initiation of tumorigenesis by promoting cell proliferation but also exert its pro-apoptosis function in the later stage of tumor development. We are proposing to test this hypothesis through the following approaches: 1) Examination of the effect of Bid in DEN-induced liver tumor paradigms and in mice of different genetic backgrounds that are known to affect the tumor initiation and cell proliferation capability; 2) Determination of the stage-specific effect of Bid on tumor development based on its function in cell proliferation and cell death using inducible transgenic and gene deletion models; 3) Exploration of the mechanisms of Bid in regulating cell cycle progression via its effects on calcium homeostasis in endoplasmic reticulum. We hope that these studies will allow us to achieve our long term goal of understanding how the growth potential of cells affects chemical carcinogenesis, particularly in the liver system, and how this potential is regulated by different genetic elements.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of HMGB1 in autophagy deficiency-induced liver pathology
-
批准号:10188516
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2018
-
负责人:XIAO-MING YIN
-
依托单位:
The Role of HMGB1 in autophagy deficiency-induced liver pathology
-
批准号:10137441
-
项目类别:
-
资助金额:$35.35万
-
财政年份:2018
-
负责人:XIAO-MING YIN
-
依托单位:
The Role of HMGB1 in autophagy deficiency-induced liver pathology
-
批准号:9751288
-
项目类别:
-
资助金额:$6.17万
-
财政年份:2018
-
负责人:XIAO-MING YIN
-
依托单位:
Mechanism and role of selective autophagy in ethanol-induced liver injury
-
批准号:8509479
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2014
-
负责人:XIAO-MING YIN
-
依托单位:
Mechanism and role of selective autophagy in ethanol-induced liver injury
-
批准号:8867956
-
项目类别:
-
资助金额:$14.79万
-
财政年份:2014
-
负责人:XIAO-MING YIN
-
依托单位:
High-Content Cell-Based Screening for Modulators of Autophagy
-
批准号:7453976
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2007
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:8237696
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7261321
-
项目类别:
-
资助金额:$27.26万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7430459
-
项目类别:
-
资助金额:$27.26万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:7627384
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
The impact of growth modulation of liver carcinogenesis
-
批准号:6968134
-
项目类别:
-
资助金额:$28.75万
-
财政年份:2005
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6569380
-
项目类别:
-
资助金额:$24.46万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:7004488
-
项目类别:
-
资助金额:$24.88万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6697252
-
项目类别:
-
资助金额:$25.67万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Bc1-2 Family Proteins in the Ischemic Neuronal Injury
-
批准号:6831662
-
项目类别:
-
资助金额:$25.56万
-
财政年份:2003
-
负责人:XIAO-MING YIN
-
依托单位:
Signal integration of the death receptor pathways
-
批准号:8237720
-
项目类别:
-
资助金额:$15.49万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6765159
-
项目类别:
-
资助金额:$22.08万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6377615
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6514224
-
项目类别:
-
资助金额:$21.72万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
FAS/TNF R1 INITIATED HEPATOCYTE DEATH IN MEDIATE BY BID
-
批准号:6633538
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2000
-
负责人:XIAO-MING YIN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: